What is well established
Large randomised placebo-controlled trials have shown substantial, sustained weight reduction with GLP-1 receptor agonists and with dual GLP-1/GIP agonists, alongside improved glycaemic control. Cardiovascular outcome trials in defined populations have shown benefit for some agents. This is real, replicated, hard-outcome evidence — a different order of thing from most of what is marketed as a peptide.
The parts left out
Weight regain after stopping is the rule, not the exception, in the trial data — which reframes this as treatment for a chronic condition rather than a course you complete. A meaningful share of weight lost is lean mass unless resistance training and adequate protein are deliberately maintained, and that matters enormously for anyone over forty. Gastrointestinal side effects are common and are the main reason people stop. Slow titration exists to manage them and skipping it is why some people have a miserable first month.
Who should not take them, or should be careful
These are prescription medicines with real contraindications and cautions — among them a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, significant gastroparesis, pregnancy or trying to conceive, and interactions with other glucose-lowering therapy where hypoglycaemia becomes a risk. Planned surgery and anaesthesia need to be discussed because of delayed gastric emptying. This is a physician conversation, and the screening is the point.
The compounded question, answered carefully
FDA-approved branded products exist for these molecules. When a drug is not in shortage, the grounds on which a pharmacy may compound a copy of it are narrow, and that position has shifted as shortages resolved. Anything sold as a cheap compounded version of a branded GLP-1, particularly as a salt form the approved product does not use, deserves hard questions about what exactly is in it and on what basis it was made. Your physician and pharmacy should be able to answer both without hesitation.
Key points
- Strong, replicated trial evidence for weight and glycaemic control.
- Regain after stopping is the norm; protect lean mass while losing.
- Real contraindications — the screening is the value.
- Compounded copies of approved drugs deserve hard questions.
AZZA Medical is not a medical provider and does not practice medicine. Medical services are provided exclusively by independently licensed physicians of our partner physician network and their affiliated professional entities.
Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
This is not emergency care. AZZA Medical does not provide urgent or emergency medical services. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.